Amway (Malaysia) Holdings Bhd (6351) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of Amway (Malaysia) Holdings Bhd MYR 4.62, price MYR 4.20, upside +10.0%, quality 69 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Amway (Malaysia) Holdings Bhd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 3.58 MYR – 6.56 MYR · fair‑value band 4.13 MYR – 5.95 MYR · the 4.20 MYR price screens below the 4.62 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Amway (Malaysia) Holdings Bhd in your weekly email
Every Wednesday you see whether Amway (Malaysia) Holdings Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Amway (Malaysia) Holdings Berhad, an investment holding company, distributes consumer products in Malaysia. The company offers health, beauty, personal care, energy, children, personal shoppers, home living, and home care products.
Show more
Amway (Malaysia) Holdings Berhad, an investment holding company, distributes consumer products in Malaysia. The company offers health, beauty, personal care, energy, children, personal shoppers, home living, and home care products. It offres products under NUTRILITE, body key, XS, ARTISTRY, G&H, GLISTER, SANITIQUE, e-spring, ATMOSPHERE, and Amway home brands through physical and online stores. Amway (Malaysia) Holdings Berhad was founded in 1976 and is headquartered in Petaling Jaya, Malaysia. Amway (Malaysia) Holdings Berhad operates as a subsidiary of GDA B.V.
Stock analysis
Amway (Malaysia) Holdings Bhd (6351) currently trades at 4.20 MYR, while our model-based Fair Value estimate is 4.62 MYR, implying the stock looks roughly 9.1% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of 6.06 MYR per share, and 18 of the 24 models we run sit above the 4.20 MYR price.
Bear case: the Asset-Based group reads lowest at 1.04 MYR, and 6 of the 24 models stay below the price. Evidence for this calculation is medium.
Scenario range: 4.13 MYR (bear) to 5.95 MYR (bull), the price of 4.20 MYR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 69/100 (solid quality), in the Consumer Cyclical sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Amway (Malaysia) Holdings Bhd reported revenue of 1.1B MYR in FY2025 versus 1.5B MYR in FY2021, a compound −6.7%/yr. Reported net income was 45.3M MYR in FY2025, compounding +5.3%/yr from FY2021.
Key figures
Market cap 750M MYR (≈ $184M) · P/E ratio 18.3 · P/S ratio 0.74 · EPS (TTM) 0.2300 MYR · Dividend yield 4.8% · Net margin 4.0% · Return on equity 15.5% · Return on assets (EBIT) 18.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 19% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −1% fair-value upside, at 10%, 6351 screens cheaper than that median.
Fair Value models
Bear 4.13 MYRFair Value 4.62 MYRBull 5.95 MYR
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.0220 MYR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−7.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.5%
Start year 2020 (pandemic). Over 10 years: +1.0% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in MYR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+4.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−0.7%
Dividend (yield on the price)4.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−1% vs −2%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 6%
Start year 2020 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−2.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Malaysia: IMF forecast 2.0% a year to 2030, 1.8% from 2016 to 2025) that is about −4.2% a year for the price.
Compare Amway (Malaysia) Holdings Bhd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Retail · 230 stocks
Beats the industry median on 7/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score69 · Top 25%
Fair Value upside+8% · Below median
Profitability
Return on equity (TTM)15% · Above median
Return on assets6% · Top 25%
Net margin (TTM)3% · Above median
Operating margin (TTM)3% · Below median
Growth and dividend
Revenue growth−11% · Bottom 25%
Dividend yield (TTM)4.8% · Above median
Valuation Multiplesvs Specialty Retail median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Amway (Malaysia) Holdings Bhd Fair Value". https://www.fairvalue-calculator.com/stock/6351
Frequently asked questions
Is Amway (Malaysia) Holdings Bhd (6351) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 4.62 MYR versus a price of 4.20 MYR, about +10% upside (undervalued).
What is the fair value of 6351?
Our model-based fair value for Amway (Malaysia) Holdings Bhd is 4.62 MYR (as of Sep 24, 2026), built from audited fundamentals. The current price: 4.20 MYR.
What is the quality score of 6351?
Amway (Malaysia) Holdings Bhd has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Amway (Malaysia) Holdings Bhd (6351)?
Our model-based price target is the fair value of 4.62 MYR (as of Sep 24, 2026) from 24 valuation models. Cautious scenario 4.13 MYR, optimistic scenario 5.95 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Amway (Malaysia) Holdings Bhd stock forecast for 2026?
Our models put fair value at 4.62 MYR, about +10% upside versus a price of 4.20 MYR (undervalued). Cautious scenario 4.13 MYR, optimistic scenario 5.95 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Amway (Malaysia) Holdings Bhd (6351)?
Amway (Malaysia) Holdings Bhd reported trailing-twelve-month revenue of about 1.1B MYR (latest available figure, as of Sep 24, 2026).
Does Amway (Malaysia) Holdings Bhd pay a dividend?
Amway (Malaysia) Holdings Bhd currently shows a dividend yield of about 4.76% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Amway (Malaysia) Holdings Bhd (6351)?
For today's price to be fair in a discounted-cash-flow model, Amway (Malaysia) Holdings Bhd would have to grow free cash flow by -2.3 % per year for five years (discount rate 12.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -0.5 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 6351 use?
Our models discount Amway (Malaysia) Holdings Bhd at 12.6 %: a base by market capitalisation (micro), damped by beta 0.15, country premium for Malaysia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Amway (Malaysia) Holdings Bhd that is -2.3 % per year a year over ten years, using the same discount rate (12.6 %) and the same formula as our fair value.
How much growth has Amway (Malaysia) Holdings Bhd (6351) delivered so far?
Over the past 5 years revenue at Amway (Malaysia) Holdings Bhd grew -0.5 % a year. The price currently implies -2.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Amway (Malaysia) Holdings Bhd (6351) growing?
The median revenue growth in the sector is +2.6 % a year. That is the yardstick for the growth priced into Amway (Malaysia) Holdings Bhd (-2.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Amway (Malaysia) Holdings Bhd (6351)?
The free-cash-flow yield on the price is 8.93 %: that much free cash flow Amway (Malaysia) Holdings Bhd produces per unit of market value. When it exceeds the discount rate of our models (12.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Amway (Malaysia) Holdings Bhd (6351)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Amway (Malaysia) Holdings Bhd it is 4.62 MYR per share (as of Sep 24, 2026), against a price of 4.20 MYR. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Amway (Malaysia) Holdings Bhd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 6351 trades below its calculated fair value: price 4.20 MYR, fair value 4.62 MYR, a gap of about +10% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6351?
No. The price is what the market pays today (4.20 MYR); the fair value is what the company's own numbers justify (4.62 MYR). For Amway (Malaysia) Holdings Bhd the two are 0.4200 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Amway (Malaysia) Holdings Bhd worth?
The market values Amway (Malaysia) Holdings Bhd at about 750M MYR (market capitalisation, as of Sep 24, 2026). Per share that is 4.20 MYR; our models calculate a fair value of 4.62 MYR per share.
What do the bullish and bearish scenarios say about 6351?
Our models span a range for Amway (Malaysia) Holdings Bhd: cautious scenario 4.13 MYR, base 4.62 MYR, optimistic 5.95 MYR per share (as of Sep 24, 2026, price 4.20 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6351?
Amway (Malaysia) Holdings Bhd trades at a price-to-earnings ratio of 18.3 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 4.62 MYR is built from several models across several years. Other multiples: P/B 0.7, P/S 0.2.
How solid is the balance sheet of Amway (Malaysia) Holdings Bhd (6351)?
Balance-sheet figures for Amway (Malaysia) Holdings Bhd (as of Sep 24, 2026): return on equity 15.5%. They feed the Quality Score of 69/100, which measures business quality independently of the share price.
How far is 6351 from its 52-week high?
Amway (Malaysia) Holdings Bhd trades at 4.20 MYR, about 19% below its 52-week high of 5.18 MYR and at the low of 4.20 MYR (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 4.62 MYR is for.
Which stocks are comparable to Amway (Malaysia) Holdings Bhd?
From the same area (Consumer Cyclical) we also value Alimentation Couche-Tard Inc, Casey's General Stores, Inc, Williams-Sonoma, Inc, Ulta Beauty, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Amway (Malaysia) Holdings Bhd stock attractive at the current price?
The data as of Sep 24, 2026: price 4.20 MYR, calculated fair value 4.62 MYR (+10%), Quality Score 69/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6351 calculated?
We run Amway (Malaysia) Holdings Bhd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 4.62 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Amway (Malaysia) Holdings Bhd currently trades 10 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Amway (Malaysia) Holdings Bhd (6351)?
The closing price on Sep 24, 2026 was 4.20 MYR. Our model-based fair value is 4.62 MYR, about +10% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Amway (Malaysia) Holdings Bhd right now?
The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of Amway (Malaysia) Holdings Bhd
How large is the market capitalisation of Amway (Malaysia) Holdings Bhd (6351)?
The market capitalisation of Amway (Malaysia) Holdings Bhd is 750M MYR (≈ $184M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Amway (Malaysia) Holdings Bhd (6351)?
The price-to-sales ratio of Amway (Malaysia) Holdings Bhd is 0.74 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Amway (Malaysia) Holdings Bhd (6351)?
Earnings per share at Amway (Malaysia) Holdings Bhd are 0.2300 MYR (price ÷ EPS = P/E 18.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Amway (Malaysia) Holdings Bhd (6351)?
The dividend yield of Amway (Malaysia) Holdings Bhd is 4.8% (payout 87.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Amway (Malaysia) Holdings Bhd (6351)?
The net margin of Amway (Malaysia) Holdings Bhd is 4.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Amway (Malaysia) Holdings Bhd (6351)?
The return on equity (ROE) of Amway (Malaysia) Holdings Bhd is 15.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Amway (Malaysia) Holdings Bhd (6351)?
On an EBIT basis the return on assets of Amway (Malaysia) Holdings Bhd is 18.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Amway (Malaysia) Holdings Bhd (6351)?
The operating margin of Amway (Malaysia) Holdings Bhd is 2.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Amway (Malaysia) Holdings Bhd (6351)?
Revenue at Amway (Malaysia) Holdings Bhd is growing −10.9% versus a year earlier (3y avg −9.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Amway (Malaysia) Holdings Bhd (6351)?
Earnings per share at Amway (Malaysia) Holdings Bhd are growing −56.7% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Amway (Malaysia) Holdings Bhd in the live analysis
One click puts Amway (Malaysia) Holdings Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
